Prostate Cancer - Results from #60

Variations in Medical Necessity Determinations Across Commercial Insurance Carriers for Prostate Cancer Procedures. August 4, 2022

Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study. August 4, 2022

Population-Level Patterns of Prostate Cancer Occurrence: Disparities in Virginia. August 4, 2022

Molecular uropathology and cancer genetics for the urologist: key findings for classification and diagnosis. August 4, 2022

Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography–targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis August 3, 2022

Merck Provides Update on Phase 3 KEYNOTE-921 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer August 3, 2022

Multifocality of Prostate Cancer and Candidacy for Focal Therapy Based on Magnetic Resonance Imaging. August 3, 2022

Intraindividual Comparison Between [18F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer Patients. August 3, 2022

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer. August 3, 2022

Artificial intelligence for prostate MRI: open datasets, available applications, and grand challenges. August 3, 2022

Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer Rotterdam. August 3, 2022

Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab). August 3, 2022

Partial gland ablation of prostate cancer: Effects of Repeat Treatment. August 2, 2022

Metformin for Prevention of Anthropometric & Metabolic Complications of Androgen Deprivation Therapy in Prostate Cancer Patients Receiving Radical Radiotherapy: A Phase II Randomized Controlled Trial. August 2, 2022

The effect of lowering cholesterol through diet on serum prostate-specific antigen levels: A secondary analysis of clinical trials. August 2, 2022

Tasks for artificial intelligence in prostate MRI. August 2, 2022

PROSHADE Protocol: Designing and Evaluating a Decision Aid for Promoting Shared Decision Making in Opportunistic Screening for Prostate Cancer: A Mix-Method Study. August 2, 2022

NRG Oncology Trial Aimed to Improve Prostate Cancer Survivor Care Planning Reaches Accrual Goal August 1, 2022

Is Urology a Gender-Biased Career Choice? a Survey-Based Study of the Italian Medical Students' Perception of Specialties August 1, 2022

Assessment of Second Primary Cancer Risk Among Men Receiving Primary Radiotherapy vs Surgery for the Treatment of Prostate Cancer. August 1, 2022

Page 4 of 1242

email news signup